1,456 research outputs found
Field aligned current observations in the polar cusp ionosphere
Vector magnetic field measurements made during a sounding rocket flight in the polar cusp ionosphere show field fluctuations in the lower F-region which are interpreted as being caused by the payload's passage through a structured field aligned current system. The field aligned currents have a characteristic horizontal scale size of one kilometer. Analysis of one large field fluctuation gives a current density of 0.0001 amp/m sq
Developing Meaningful Student-Teacher-Scientist Partnerships
This article describes the Earth System Scientist Network, in which students and teachers participate in research projects with scientists. In these projects the scientists can take advantage of having an extended research team, and the students and teachers can contribute to a research project while developing skills in inquiry and expanding content knowledge in Earth system science. Several issues must be addressed in order to facilitate these partnerships: identifying the scientific research questions, the data that the students will analyze, the requirements for participating schools, and the tools and protocols that the students and teachers will use during their research. Other logistical issues must also be addressed, such as assuring that instruments and tools are available to the teachers and students, providing the background information and training they will need, providing additional research questions that can help spark students' interest, and recognizing students and teachers for their contributions. Educational levels: Graduate or professional
Magnetic field observations in high beta regions of the magnetosphere
OGO for magnetic field observations in high beta regions of magnetospher
Response to proposed rulemaking on Bayh Dole
Comment on: Doc # 2020-27581
Federal Register / Vol. 86, No. 1 / Monday, January 4, 2021 / Proposed Rules
Agency: National Institute of Standards and Technology (NIST), United States Department of Commerce
Docket identification: 201207-0327
Notice of proposed rulemaking: Rights to Federally Funded Inventions and Licensing of Government Owned Inventions, 37 CFR 401 and 404
Respondent: Fred D. Ledley, M.D. Director, Center for Integration of Science and Industry; Professor, Departments of Natural & Applied Science, Management; Bentley University, Waltham, MA, 02452. Email: [email protected], Website: www.bentley.edu/sciindustr
Center for Integration of Science and Industry - Response to OSTP Bioeconomy RFI
RESPONSE TO: AGENCY: Office of Science and Technology Policy (OSTP). ACTION: Notice of request for information (RFI) for Bioeconomy Federal Register /Vol. 84, No. 175 /Tuesday, September 10, 2019 /Notices, page 47561 Transmitted electronically to [email protected]
What specific actions could the U.S. Government take to reinforce a values-based ecosystem that will guide the transformation and expansion of the U.S. Bioeconomy, in both the shortand long-term?
This response addresses specific actions the U.S. Government could take to ensure sustainable funding for the basic research that provides the foundation for the U.S. Bioeconomy. Empirical evidence demonstrates that a mature body of basic research is essential for the efficient discovery and development of new medicines, and recent studies have demonstrated the scale of the public sector (NIH) contribution to this research. This funding is, however, under threat. U.S. Government action is required to ensure sustainable funding for basic research. Specific actions by the U.S. Government could include:
1. Make a long-term commitment to sustained public funding of basic science by the NIH at levels at least equal to 2003 in constant dollars;
2. Ensure equitable returns to the public sector from the licensing of federally funded research for development in the biopharmaceutical industry;
3. Require accounting recognition of basic and applied research spending as a capital investment that produces a tangible asset (intellectual property);
4. Facilitate innovative investment instruments that provide long-term support for basic and applied research through tax exempt bonds
Could Human Genome Sciences have become Standard Oil?
Human Genome Sciences (HGS) was not a company with normal ambitions. At its inception, HGS aspired to dominate not only the field of genomic science, but also emerging markets for regenerative medicines designed to meet the needs of ageing populations. Fred Ledley asks whether HGS could have become the Standard Oil of our generation
How to lie with (FDA) statistics
The FDA approved 27 new drugs in 2013. Is this a downward trend? Is it an upward trend? Does it suggest that the pharmaceutical industry is failing, or that genomics is finally paying dividends? We revisit Darrell Huff’s 1954 classic How to Lie with Statistics for insights into these pressing questions
- …
